{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T16:21:30Z","timestamp":1777911690986,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016060","name":"Stichting De Cock-Hadders","doi-asserted-by":"publisher","award":["2019-08"],"award-info":[{"award-number":["2019-08"]}],"id":[{"id":"10.13039\/100016060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jcf.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:11:55Z","timestamp":1695877915000},"page":"461-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol"],"prefix":"10.1016","volume":"23","author":[{"given":"Anna","family":"Bertolini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent W.","family":"Bloks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6554-0239","authenticated-orcid":false,"given":"Marijn","family":"Wilmink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6268-3404","authenticated-orcid":false,"given":"Ivo P.","family":"van de Peppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roos","family":"Eilers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sake","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-2861","authenticated-orcid":false,"given":"Henkjan","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3919-5437","authenticated-orcid":false,"given":"Johan W.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2023.09.015_bib0001","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.25733","article-title":"Increasing life expectancy in cystic fibrosis: Advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0002","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.jcf.2023.09.015_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPG.0000000000000784","article-title":"Pancreatic enzyme replacement therapy and coefficient of fat absorption in children and adolescents with cystic fibrosis","volume":"61","author":"Woestenenk","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2023.09.015_bib0004","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1515\/cclm-2019-1112","article-title":"Influence of pancreatic status on circulating plasma sterols in patients with cystic fibrosis","volume":"58","author":"Gelzo","year":"2020","journal-title":"Clin Chem Lab Med (CCLM)"},{"key":"10.1016\/j.jcf.2023.09.015_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-011-0185-9","article-title":"Intestinal obstruction syndromes in cystic fibrosis: Meconium ileus, distal intestinal obstruction syndrome, and constipation","volume":"13","author":"Van Der Doef","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jcf.2023.09.015_bib0006","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1172\/JCI38662","article-title":"Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator\u2013dependent bicarbonate secretion","volume":"119","author":"Garcia","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2023.09.015_bib0007","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/hep.30148","article-title":"Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients","volume":"69","author":"Bo\u00eblle","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2023.09.015_bib0008","first-page":"197","article-title":"Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota","volume":"8","author":"Fiorotto","year":"2019","journal-title":"CMGH"},{"key":"10.1016\/j.jcf.2023.09.015_bib0009","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gut.34.8.1137","article-title":"Intestinal bile acid malabsorption in cystic fibrosis","volume":"34","author":"O'Brien","year":"1993","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2023.09.015_bib0010","article-title":"The Beneficial Effects of Apical Sodium-Dependent Bile Acid Transporter Inactivation Depend on Dietary Fat Composition","volume":"64","author":"Peppel","year":"2020","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0011","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M094607","article-title":"Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice","volume":"60","author":"van de Peppel","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2019_238","article-title":"The Pharmacology of Bile Acids and Their Receptors","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0013","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/er.2018-00134","article-title":"Fibroblast Growth Factor 15\/19: From Basic Functions to Therapeutic Perspectives","volume":"39","author":"Somm","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jcf.2023.09.015_bib0014","doi-asserted-by":"crossref","first-page":"G404","DOI":"10.1152\/ajpgi.00188.2018","article-title":"Defective FXR-FGF15 signaling and bile acid homeostasis in cystic fibrosis mice can be restored by the laxative polyethylene glycol","volume":"316","author":"Bertolini","year":"2019","journal-title":"Am J Physiol-Gastrointest Liv Physiol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0015","first-page":"47","article-title":"Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice","volume":"9","author":"Ikpa","year":"2020","journal-title":"CMGH"},{"key":"10.1016\/j.jcf.2023.09.015_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117599","article-title":"Cholic Acid Induces a Cftr Dependent Biliary Secretion and Liver Growth Response in Mice","volume":"10","author":"Bodewes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcf.2023.09.015_bib0017","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jcf.2018.09.001","article-title":"IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation","volume":"18","author":"Van De Peppel","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.09.015_bib0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcmgh.2019.04.013","article-title":"Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota","volume":"8","author":"Fiorotto","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0019","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1002\/j.1460-2075.1995.tb00119.x","article-title":"A mouse model for the cystic fibrosis \u0394F508 mutation","volume":"14","author":"Hikke Van Doorninck","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.jcf.2023.09.015_bib0020","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1017\/S0007114520002421","article-title":"An early-life diet containing large phospholipid-coated lipid globules programmes later-life postabsorptive lipid trafficking in high-fat diet- But not in low-fat diet-fed mice","volume":"125","author":"Ronda","year":"2021","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jcf.2023.09.015_bib0021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"De Boer","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0022","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cpmo.16","article-title":"Measurement of Intestinal and Peripheral Cholesterol Fluxes by a Dual-Tracer Balance Method","volume":"6","author":"Ronda","year":"2016","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0023","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcf.2023.09.015_bib0024","doi-asserted-by":"crossref","first-page":"G1411","DOI":"10.1152\/ajpgi.00181.2007","article-title":"Pathophysiological basis of liver disease in cystic fibrosis employing a \u0394F508 mouse model","volume":"294","author":"Freudenberg","year":"2008","journal-title":"Am J Physiol-Gastrointest Liv Physiol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcf.2011.03.008","article-title":"Persistent fat malabsorption in cystic fibrosis; lessons from patients and mice","volume":"10","author":"Wouthuyzen-Bakker","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2023.09.015_bib0026","doi-asserted-by":"crossref","first-page":"70","DOI":"10.14797\/mdcj-15-1-70","article-title":"The TICE Pathway: Mechanisms and Lipid-Lowering Therapies","volume":"15","author":"Grefhorst","year":"2019","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.jcf.2023.09.015_bib0027","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.ygeno.2019.06.028","article-title":"Transcriptome analysis of the distal small intestine of Cftr null mice","volume":"112","author":"Ikpa","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.jcf.2023.09.015_bib0028","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1203\/00006450-198206000-00019","article-title":"Intestinal bile acid malabsorption in cystic fibrosis: A primary mucosal cell defect","volume":"16","author":"Fondacaro","year":"1982","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0029","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1651-2227.1985.tb14931.x","article-title":"Bile Acid Malabsorption in Cystic Fibrosis; Membrane Vesicles, a Tool for Revealing the Role of the Ileal Brush Border Membrane","volume":"74","author":"Rooij","year":"1985","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jcf.2023.09.015_bib0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1203\/00006450-198803000-00018","article-title":"In vivo bile acid uptake from terminal ileum in cystic fibrosis","volume":"23","author":"Thompson","year":"1988","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0031","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1152\/ajpgi.00170.2004","article-title":"FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade Animal Studies","volume":"288","author":"Li","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0032","series-title":"Polyethylene Glycol - StatPearls","author":"Dabaja","year":"2023"},{"key":"10.1016\/j.jcf.2023.09.015_bib0033","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1203\/00006450-199610000-00002","article-title":"In vivo measurement of chloride and water secretion in the jejunum of cystic fibrosis patients","volume":"40","author":"Teune","year":"1996","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0034","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1113\/jphysiol.2012.232124","article-title":"Rescue of epithelial HCO 3- secretion in murine intestine by apical membrane expression of the cystic fibrosis transmembrane conductance regulator mutant F508del","volume":"590","author":"Xiao","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0035","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: opening the X-files","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jcf.2023.09.015_bib0036","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0037","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jcf.2023.09.015_bib0038","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/hep4.1266","article-title":"Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice","volume":"2","author":"Debray","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcf.2023.09.015_bib0039","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thorax.57.7.596","article-title":"Relationship between nutritional status and lung function in cystic fibrosis: Cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project","volume":"57","author":"Steinkamp","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2023.09.015_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000614","article-title":"How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey","volume":"7","author":"Smith","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jcf.2023.09.015_bib0041","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap - bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcf.2023.09.015_bib0042","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2101","article-title":"Pharmacological correction of a defect in PPAR-\u03b3 signaling ameliorates disease severity in Cftr-deficient mice","volume":"16","author":"Harmon","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jcf.2023.09.015_bib0043","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/hep.28000","article-title":"Stimulation of nuclear receptor peroxisome proliferator-activated receptor-\u03b3 limits NF-\u03baB-dependent inflammation in mouse cystic fibrosis biliary epithelium","volume":"62","author":"Scirpo","year":"2015","journal-title":"Hepatology"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323009190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199323009190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:32:16Z","timestamp":1777649536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199323009190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1569199323009190"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2023.09.015","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of intestinal and liver features in cystic fibrosis mice by the osmotic laxative polyethylene glycol","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}